PROCESSA PHARMACEUTICALS INC (PCSA) Stock Cash Flow
NASDAQ:PCSA - Nasdaq - US74275C3043 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -11.96M | -11.85M | -11.12M | -27.42M | -11.43M | |||
| Depreciation Amortization | 1.00K | 800.00 | 200.00 | 788.50K | 791.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | -530.60K | |||
| Change In Working Capital | -747.10K | -112.40K | 605.20K | 543.60K | -1.18M | |||
| Interest Paid | N/A | 1.20K | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 778.40K | 716.70K | 2.45M | 16.49M | 3.63M | |||
| OPERATING CASH FLOW | -11.93M | -11.24M | -8.06M | -9.61M | -8.72M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -3.20K | -2.80K | N/A | N/A | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -3.20K | -2.80K | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -5.80K | -5.20K | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 5.92M | 7.76M | 6.32M | -300.00K | 10.05M | |||
| Other Financing Activity | -7.40K | -24.50K | -52.70K | -88.80K | -250.90K | |||
| FINANCING CASH FLOW | 5.91M | 7.73M | 6.27M | -388.80K | 9.80M | |||
| CHANGE IN CASH | -6.02M | -3.51M | -1.80M | -9.99M | 1.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.93M | -11.24M | -8.06M | -9.61M | -8.72M | |||
| Capital Expenditure | N/A | -3.20K | -2.80K | N/A | N/A | |||
| FREE CASH FLOW | -11.93M | -11.25M | -8.07M | -9.61M | -8.72M | |||
All data in USD